Website News and Research

RSS

Lupus Foundation of America to educate people with lupus on clinical trial participation

It has been more than 50 years since the U.S. Food and Drug Administration (FDA) last approved a new medicine specifically for lupus – when Dwight D. Eisenhower was president. Existing treatments have been "borrowed" from other disorders and the risk/benefit ratio of these treatments is far from optimal. However, hope is on the horizon.

2 Sep 2009

American Imaging Management discusses about diagnostic imaging in a journal

American Imaging Management(R) (AIM), an operating subsidiary of WellPoint, Inc. and one of the leading companies in the radiology benefit management industry, today commended articles on diagnostic imaging that appear in the August 27, 2009 issue of the New England Journal of Medicine.

1 Sep 2009

Advertising campaign launched to encourage Americans practice healthy habits to prevent the spread of H1N1 flu

The Department of Health and Human Services, the Department of Homeland Security, the Department of Education and Sesame Workshop, the nonprofit educational organization behind Sesame Street, have teamed up to launch a new, national public service advertising campaign designed to encourage American children and families to practice healthy habits and to take steps to prevent the spread of the 2009 H1N1 flu virus. The PSAs featured in this campaign can be viewed on www.flu.gov.

1 Sep 2009

CPRIT releases five cancer research requests after receiving first funding

The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.

1 Sep 2009

Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present at the UBS Global Life Sciences Conference in New York at 11:00 a.m. Eastern Time on Monday, September 21, 2009. Mr. Kazimi will provide an update on the Company and its Caldolor product, which Cumberland is preparing to launch following its recent approval by the Food and Drug Administration.

1 Sep 2009

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

The Centers for Disease Control and Prevention (CDC) and the American Academy of Neurology (AAN) are requesting neurologists to report any possible new cases of Guillain-Barr- syndrome (GBS) following 2009 H1N1 flu vaccination using the CDC and U. S. Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS).

1 Sep 2009

Medical Cannabis Management reports initial success in dispensary management lead funnel

Rapid Fire Marketing (Pink Sheets: RFMK) d.b.a. Medical Cannabis Management (MCM) (http://medicalcannabismanagement.com ) announced today that the first few weeks have been very successful with regards to new dispensary management leads as well as connecting with significant organizations for collaborative ventures.

1 Sep 2009

Geron to present updates on product development programs at four investor conferences in September

Geron Corporation today announced that the company will present updates of its product development programs at four investor conferences in the month of September.

31 Aug 2009

IntelGenx Technologies shareholder conference call to update shareholders on CPI-300

Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. ("IntelGenx") will be holding a shareholder conference call to update shareholders on the company's CPI-300 product and remark on related legal proceedings. The call will be held on Tuesday September 1, 2009 at 2.30 p.m. Eastern Standard Time.

31 Aug 2009

Emotions still running high in health care reform debate

In the first, NPR notes: Conservative political activists associated with the so-called 'Tea Party' protests have started a cross-country bus convoy dubbed the Tea Party Express. They plan to stop in 33 cities. Tea Party Express organizer Mark Williams, also a conservative talk show host, said there is a lot of dissatisfaction in the country right now focused on issues from health care reform to the national debt.

30 Aug 2009

Food guide application for iPhone/iPod users impacted by celiac/coeliac disease and food allergies

The iPhone(TM)/iPod(R) touch application, iCanEat OnTheGo Gluten & Allergen Free(TM), expands the suite of innovative solutions to help those impacted by celiac/coeliac disease, food allergies or intolerances safely eat out anywhere.

29 Aug 2009

AARP members urge Congressman Schock to tackle health care reform

While Congressman Schock may be taking a break from Washington, AARP is making sure he doesn't get a break from the need to fix the broken health care system.

29 Aug 2009

Vision document to guide CHA's support to health reform

The Catholic Health Association of the United States (CHA) has long been committed to a goal of health coverage for all people in the United States. CHA has not, however, endorsed any of the bills currently under consideration.

29 Aug 2009

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.

28 Aug 2009

Forest Laboratories to host a conference call for discussing the results of Daxas Phase III clinical trials

Forest Laboratories, Inc., an international manufacturer and marketer of pharmaceutical products and Nycomed, a privately owned pharmaceutical company, will host a conference call at 7:15 AM EDT on Friday, August 28, 2009.

28 Aug 2009

AVANIR raises funds to develop and commercialize Zenvia for PBA

AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced it had raised gross proceeds of approximately $10.6 million via the sale of approximately 4.5 million shares of common stock at a weighted average price of $2.34 per share.

28 Aug 2009

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.

28 Aug 2009

Maxim Health Systems' website provides detailed information about flu vaccination

Maxim's dedicated flu Web site provides detailed information about the flu vaccination and allows consumers to locate seasonal flu clinics in their area by searching by zip code. In addition, Maxim is preparing to launch several new online resources for consumers to protect themselves and their families this flu season.

28 Aug 2009

Champions Biotechnology reports higher year-on-year operating revenues for fiscal year 2009

Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2009. Full details of the Company's financial results are available in the Company's Form 10-K available at www.championsbiotechnology.com.

28 Aug 2009

CREW opposes misleading ad about healthcare released by MSNBC

Today, Citizens for Responsibility and Ethics in Washington (CREW) sent a letter to MSNBC President Phil Griffin asking that MSNBC stop airing an ad sponsored by the U.S. Citizens Association. The ad, which ran at least once on August 27, 2009, during Morning Joe, violates Federal Communications Commission (FCC) regulations and NBC’s advertising policy.

28 Aug 2009

Website News and Research

Lupus Foundation of America to educate people with lupus on clinical trial participation

American Imaging Management discusses about diagnostic imaging in a journal

Advertising campaign launched to encourage Americans practice healthy habits to prevent the spread of H1N1 flu

CPRIT releases five cancer research requests after receiving first funding

Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

Medical Cannabis Management reports initial success in dispensary management lead funnel

Geron to present updates on product development programs at four investor conferences in September

IntelGenx Technologies shareholder conference call to update shareholders on CPI-300

Emotions still running high in health care reform debate

Food guide application for iPhone/iPod users impacted by celiac/coeliac disease and food allergies

AARP members urge Congressman Schock to tackle health care reform

Vision document to guide CHA's support to health reform

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

Forest Laboratories to host a conference call for discussing the results of Daxas Phase III clinical trials

AVANIR raises funds to develop and commercialize Zenvia for PBA

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

Maxim Health Systems' website provides detailed information about flu vaccination

Champions Biotechnology reports higher year-on-year operating revenues for fiscal year 2009

CREW opposes misleading ad about healthcare released by MSNBC

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News